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INTRODUCTION 
Conditional lethal mutants defective in par- 
ticular steps of the  cell division cycle have 
recently been isolated in several types of 
eukaryotic cells (Hartwell, '74; Nurse et al., 
'76; Frankel e t  al., '76; Orr and Rosenberger, 
"76; Morris, '76; Sato, '76; Basilico, '77; 
Siminovitch and Thompson, '78). Among the 
several uses to which such mutants can be put 
is the derivation of temporal and functional 
sequence maps of cell cycle events. By a tem- 
poral map, I mean very simply a diagram sum- 
marizi. f: the temporal order of events during 
the cell cycle (fig. 11, such as could in principle 
be obtained by using a perfectly synchronous 
culture and methods for accurately and in- 
stantaneously monitoring each cell cycle 
event. Note that the  temporal map per se pro- 
vides no information on how the cell arranges 
for events to be carried out in an appropriate 
temporal order, or even on whether the tem- 
poral order indicated by the map is fixed or 
flexible. By a functional sequence map, I mean 
a diagram summarizing the functional in- 
terrelatedness of various cell cycle events. 
Figure 2 shows several possible examples. 
Note tha t  a functional sequence map has 
implications for, bu t  may not fully determine, 
the corresponding temporal map. For example, 
if three events occur in the dependent series 
A B: C,, then they must also occur in the 
fixed temporal order A then B then C. On the 
other hand, knowing that events A and B are 
in parallel pathways (fig. 2c) tells one nothing 
of their actual temporal order, and even sug- 
gests that  the temporal order may be flexible. 
An unambiguous discussion of the use of 
conditional lethal cell cycle mutants for con- 
structing temporal and functional sequence 
maps requires the recognition that there are 
several different times in the cell cycle that 
are relevant to consideration of any particular 
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mutant (fig. 3). First, there is the interval of 
the cycle during which the gene product in 
question normally carries out its essential 
function. Second, there is the interval of the 
cycle during which the gene product in ques- 
tion is normally synthesized. [Note that some 
gene products that function during discrete 
intervals of the cycle may be synthesized con- 
tinuously throughout the cycle, while others 
(as shown in fig. 3) may be synthesized shortly 
before their times of function. Other patterns 
are also possible.1 Third, there is the time in 
the cycle at which the first landmark cvcnt (an 
event detectable biochemically or morphologi- 
cally with currently available techniques) 
that is known to be defective in the mutant 
normally occurs. This first known defective 
landmark event has been termed the diag- 
nostic landmark by Hartwell ('74). Note that i t  
may occur considerably later in the cycle than 
the time of function of the gene product in 
question. For example, one could have a 
mutant in which a failure of gene product 
function led to a failure to complete event A 
(fig. Za), but in which the failure of event E to 
occur would be the first morphological or bio- 
chemical indication that cell cycle progress 
was arrested. Fourth, there is the terminal 
phenotype that each mutant cell ultimately at-  
tains after an extended incubation under re- 
strictive conditions. This is shown as a branch 
I Such mutants are appropriately termed cell cycle mutants. Condi- 
tional lethal mutants with more general metabolic defects (e.g., 
mutants defective in ATP generation or in protein synthesis) will of 
course also cease to progress through the cell cycle under restrictive 
conditions, although, in contrast to cell cycle mutants, they will dis- 
play no distinctive terminal phenotype (see fig. 3 and associated dis- 
cussion, below). Studies of such metabolic mutants may illuminate 
some aspects of the cell cycle (see ftn. 41, but it seems to me that a 
failure to distinguish clearly between such mutants and cell cycle 
mutants is an impediment to clear thinking about the cell cycle and 
the uses of mutants in analyzing it. I think this argument is not 
vitiated hy the recognition that there are probably intermediate 
cases, that is, mutations in genes whose products function in two or 
three discrete cell cycle steps. Except as otherwise noted, all 
mutants discussed in this paper are cell cycle mutantssensu stricto. 
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Time i n  the Cell Cycle 
Fig. 1 A temporal map of cell cycle events. The map 
indicates that event A occurs earlier than event B, which 
occurs earlier than event C, and so on, but does not indi- 
cate the functional relations that may (or may not) exist 
among these several events. Note that “events” may be of 
several types. For example, event A might be “end of the 
period during which gene product x functions”; event B 
might be “beginning of the period during which gene prod- 
uct y functions”; event C might be “beginning of the pe- 
riod during which gene product z is synthesized; event D 
might be “the completion of DNA synthesis”; etc. 
ecution points (Hartwell e t  al., ’73). For exam- 
ple, for the gene described in figure 3, a tight 
conditional-labile allele (in which the gene 
product lost its activity instantaneously and 
completely upon a shift from permissive to re- 
strictive conditions) would have an  execution 
point just a t  the end of the “time of gene prod- 
uct function”. A leaky conditional-labiZe allele 
(in which the gene product lost its activity 
gradually or incompletely under restrictive 
conditions) would have an execution point 
earlier in the cycle; how early would depend 
on the degree of leakiness. A tight conditional- 
for-synthesis allele (in which the mutant 
from the cycle in figure 3, in order to empha- 
size that the terminal phenotype cannot in 
general be regarded as a normal stage of the 
cycle at which cycle progress has suddenly be- 
come arrested (as by an instantaneous and 
perfect fixation procedure). For example, if 
the mutant gene product normally functions 
to catalyze event C (fig. 2b, c, or d), any event 
that  normally occurs after event C,  but that is 
. .  
gene product retained its activity under re- 
strictive conditions, but new active gene prod- 
uct could not be formed) would have an  execu- 
tion point at the end of the “time of gene prod- 
uct Synthesis”, or at whatever earlier time the 
cell had synthesized enough active gene prod- 
uct to see it through its current cell cycle.3 
USE OF CONDITIONAL LETHAL MUTANTS FOR 
TEMPORAL MAPPING 
independent of C (e.g., events D and E, fig. 2b, 
C .  This leaves the cell in a situation (i.e., D and 
that does not 
arise in the course of a normal cycle. Also, i t  is 
At first glance, one might imagine at least 
use of conditional lethal cell cycle mutants for 
the temporal mapping of cell cycle events. 
c, or d) will Occur despite the Of three potentially fruitful approaches to the 
not 
Clear that most cell cycle mutants continue to *For the conditional mutants most commonly used (i.e., tempera- 
ture-sensitive mutants), the corresponding terminology would be 
3&me mutants display execution pints in the cycle previous to 
the cycle of reference (or in even earlier cycles); that is. cells after 
the execution point divide successfully twice (or more) after a shift 
to restrictive conditions. before their daughters arrest. with the aD- 
increase their Cell masses under restrictive 
conditions, SO that a mutant cell blocked (for 
example) at nuclear division becomes much 
lartzer than a normal Cell a t  the time Of nuCle- 
“temperatur~labile” and “temperature-sensitive-for-synthesis”. 
propriate terminal phenotype, in the cycle of reference (Hartwell et 
a]., ’73). Hartwell (‘74) bas described such mutants as “failing to 
exhibit first cycle arrest”. Both intuition and the presence in most 
cases of other alleles of the same genes that do exhibit first cycle 
arrest (Hartwell et al., ’73) suggest that such mutants are generally 
leaky alleles. However, it is certainly possible that some gene prod- 
ucts are synthesized in adequate amounts, or even complete their 
functions, in anticipation of cycles that are to come 
a r  &vision. 
Finally, for each conditional mutant allele 
of a particular gene there is an execution point 
(not shown in fig. 3). ~h~ execution point is de- 
fined operationally: it is that time in the cell 
cvcle after which a shift from permissive to re- 
sirictive conditions can no longer prevent the 
mutant cell from successfully completing the 
current cell cycle. Thus, a cell that  is prior to 
the execution point at the time of the shift to 
restrictive conditions arrests, with the ap- 
propriate terminal phenotype, without having 
divided under the restrictive conditions; a cell 
that is past the execution point at the time of 
the shift divides once successfully under the 
restrictive conditions, then arrests, with the 
appropriate terminal phenotype, in the subse- 
quent cell cycle. It is crucial to realize that the 
execution point is an allele-specific, rather 
than a gene-specific, parameter. In other 
words, different conditional lethal alleles of 
the same gene can have vastly different ex- 
Fig. 2 Examples of possible functional sequence maps 
for a set of cell cycle events. In each diagram, arrows con- 
nected head-to-tail denote that  the associated events oc- 
cur in a dependent series. For example, diagram a indi- 
cates that  event B is dependent upon event A; that is, 
event B cannot be completed unless event A has been 
completed. (However, event A is not dependent upon event 
B, and can be completed even when completion of event B 
is blocked.) Note that events in a dependent series obey 
the transitive rule: if (as in diagram a) C is dependent 
upon B, which is dependent upon A, then C is also depen- 
dent upon A. Events associated with the same arrow (e.g., 
events F and G in diagram d )  are interdependent: neither 
can be completed while completion of the other is blocked. 
Events not connected by a series of head-to-tail arrows 
k.6, A and B in diagram b;  A and B in diagram c; or C 
and D in diagram d )  are said to be independent, or in par- 
allel pathways : either event can be completed while com- 
pletion of the other is blocked. 
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a .  Events occur i n  a dependent se r ies :  
b. Events a re  independently t r i g g e r e d  by some c e n t r a l  "c lock"  





E "c lock"  > 
- _  
c. Events occur i n  two p a r a l l e l  pathways, each o f  which 
c o n s t i t u t e s  a dependent se r ies :  
A C F +-- 
ALL 
d. Events occur i n  two p a r a l l e l  pathways (D-E-H and C-F,G-I) , 
each o f  which i s  dependent on an e a r l i e r  event ( B ) ,  and 
each of which i s  p r e r e q u i s i t e  f o r  a l a t e r  event ( J ) :  
Figure 2 
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Cy t o k i n es i s 
I 
Time of F i r s t  Event Known t o  
Be Defect ive i n  the  Mutant 
Time of Gene 
Product Funct ion 
Time of Gene 
Product Synthesis 
Fig. 3 Diagram of the cell cycle showing several of the times relevant to consideration of a particular 
hypothetical conditional lethal cell cycle mutant. 
First, one might shift mutant cells to restric- 
tive conditions and ask when a detectable in- 
terruption of cell cycle progress occurs. How- 
ever, since the gene product identified by the 
mutation may be synthesized, and function, at 
any time prior to the first morphologically or 
biochemically detectable defect (see fig. 3 and 
the INTRODUCTION), such a n  experiment yields 
no temporal information beyond that obtaina- 
ble (more reliably) with a wild-type strain. 
Second, one might allow mutant cells to arrest 
under restrictive conditions, then return them 
to permissive conditions and measure the time 
until some biochemically or morphologically 
detectable landmark event occurs. However, 
the hope of determining by such experiments 
when in the cycle (relative to the landmark 
event) different mutants are blocked seems to 
rest on the dubious and difficult to test as- 
sumption that  all mutants recover immedi- 
ately (or, at least, that  different mutants re- 
cover with identical kinetics) upon a return to 
permissive conditions. Even if a mutant gene 
product recovers its full activity immediately 
upon a return to permissive conditions, the 
time required to move from an abnormaI ter- 
minal phenotype (see fig. 3 and the INTRODUC- 
TION) to a landmark event may not bear any 
simple relation to the time required to move 
from the time of gene product function to the 
landmark event along the normal cell cycle 
path. 
A third, and much more promising, ap- 
proach to the use of cell cycle mutants for tem- 
poral mapping is the determination of mutant 
execution  point^.^ Execution points can be 
determined using synchronous cultures (for 
example, Culotti and Hartwell, ’71). “Selec- 
tion synchrony” is preferred to “induction 
‘ See footnote 5, on page 397 
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synchrony" for the usual reasons (Mitchison, 
'71, pp. 25-57). [Note, in particular, that if par- 
allel pathways of cell cycle events exist (fig. 
2b-d), the treatment used for induction may 
synchronize the cells with respect to some 
pathways, but not with respect to the pathway 
in which the mutant gene product functions, 
and a grossly misleading measurement of the 
execution point would result.] Direct analysis 
of fractionated cultures (Mitchison, '71, p. 50; 
Wells and James, '72) will probably be a pref- 
erable alternative to synchronous cultures in 
execution point determinations, as in other 
applications. 
Execution points can also be determined by 
following the development of individual cells 
after a shift to restrictive conditions, and re- 
lating whether or not each cell completes a 
normal cycle to its position in the cycle at  the 
time of the shift to restrictive conditions 
(Culotti and Hartwell, '71; Hartwell, '74, '76). 
A limitation of this approach is that it 
requires a method (such as measurement of 
bud size in yeast) for assessing the cycle posi- 
tion of individual cells a t  the time of the shift 
to restrictive conditions. More ingenuity will 
be needed to overcome this limitation with 
organisms other than yeast, but the problems 
do not seem insurmountable. For example, 
time lapse cinematography of cells during the 
period prior to the shift to restrictive condi- 
tions should allow each cell whose develop- 
ment is followed after the shift to be charac- 
terized as regards the time of its last previous 
division under permissive conditions. It also 
seems possible that  a combination of DNA- 
autoradiography plus cell size measurements 
might allow cells to be characterized a t  least 
as to whether they were in G1, S, or G2 at the 
time of the shift. I t  also seems likely that the 
continuing development of cell scanning de- 
vices and of techniques for monitoring bio- 
chemical markers of cell cycle progress will 
further enlarge the possibilities for applying 
the individual cell approach to organisms 
other than yeast. 
The most widely applicable method of deter- 
mining execution points is to measure the 
fraction of cells capable of dividing when an 
asynchronous population is shifted to restric- 
tive conditions. From this fraction the execu- 
tion point can be calculated by making the ap- 
propriate correction for the age distribution of 
the population (Hartwell et  al., '73; Howell 
and Naliboff, '73; Howell et  al., '75; Nurse et  
al., '76; Orr and Rosenberger, '76). This ap- 
, 
- 
proach has a t  least two inherent dangers. 
First, unless the results are corroborated by 
observations on single cells or on synchronous 
cultures, as described above, one must assume 
that the mutant of interest really has a well 
defined execution point (i.e., that the cells 
that divide after the shift to restrictive condi- 
tions really are the cells that were latest in 
the cycle a t  the time of the shift). [Il- 
lustrations of such corroboration are provided 
by Hartwell et al. ('73) ; Howell and Naliboff 
('73); and Hartwell ('741.1 Second, one must 
assume that the mutant cells growing under 
permissive conditions have a normal cycle age 
distribution; given the nature of conditional 
lethal mutations, this assumption is certainly 
not always safe (Hartwell et al., '73; Pringle, 
'75; Nurse et  al., '76). 
Regardless of how execution point data are 
obtained, they must be interpreted with cau- 
tion. I t  should be clear from figure 3 and the 
associated discussion (see INTRODUCTION) 
that ,  in principle, determining execution 
points can yield valuable information on the 
times in the cell cycle at which various essen- 
tial gene products are synthesized, and on the 
times a t  which they complete their essential 
functions. However, it should also be clear 
that this information cannot be obtained un- 
less it is known which of the mutant alleles 
studied are tight conditional-labile, which are 
tight conditional-for-synthesis, and which are 
leaky (see INTRODUCTION). When the products 
of cell cycle genes have been identified, and 
quantitative assays for these products de- 
veloped, such discriminations among alleles 
can be made by direct assays of the gene prod- 
ucts of interest after shifts to restrictive con- 
ditions. Before this happy day, one must rely 
on indirect arguments, of which a t  least three 
seem likely to be useful. First, if the one or few 
available mutant alleles of a particular gene 
all fail to exhibit first cycle arrest, they should 
be presumed leaky until proven innocent (see 
ftn. 31, and strong conclusions should not be 
5 Note that inhibitors that affect specific cell cycle events also 
have execution points (defined analogously to those for cell cycle 
mutants). The following discussion of the determination and in- 
terpretation of execution point data applies to inhibitor execution 
points as well as to mutant execution points. Note also that mutants 
and inhibitors with more general metabolic defects (see ftn. 1) have 
"transition points" (Howell and Naliboff, '73 and Howell et al., '75) 
that are similar to execution points except for the lack of a distinc- 
tive terminal phenotype attained hy all cells. Determination of 
these transition points can yield valuable information about the 
dependence of cell cycle events on general metabolism (e.g., at what 
point does the completion of cell division become independent of con- 
tinued protein synthesis?). The following discussion of the deter- 
mination and interpretation of execution point data applies also to 
these transition points. 
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drawn from their execution points. Second, if 
multiple mutant alleles of a particular gene 
are available, one can compare their execution 
points. The latest of these execution points 
sets a limit on the time of gene product func- 
tion: the gene product in question cannot com- 
plete its function earlier in the cycle than the 
latest known execution point. Moreover, if 
enough mutant alleles of a particular gene are 
available that a clear pattern in the execution 
points is discernible (several execution points 
clustered a t  a certain time, all other execution 
points earlier in the cycle), one is probably 
justified in concluding that the clustered 
execution points mark the time a t  which the 
gene product completes its essential function. 
Finally, if mutants are isolated in a strain 
carrying a tight temperature-labile nonsense 
suppressor, then nonsense mutations in cell 
cycle genes will behave like tight tempera- 
ture-sensitive-for-synthesis alleles, and deter- 
mination of their execution points will allow 
statements about when the gene products are 
synthesized. [See Pringle ('75) for further dis- 
cussion of the advantages of, and prospects 
for, this approach to mutant isolation.] 
The arguments of the preceding paragraph 
are subject to one final caveat, namely that i t  
is not clear to what extent genetic background 
differences may affect the execution points 
determined for a particular mutant allele. 
Since it seems likely that the effects may be 
significant, conclusions based on execution 
points should be tentative until the possible 
effects of genetic background differences have 
been assessed directly. 
USE OF CONDITIONAL LETHAL MUTANTS 
FOR FUNCTIONAL SEQUENCE 
MAPPING 
Functional sequence maps should be useful 
in at least two important ways. First, i t  seems 
clear that the events that  comprise a cell divi- 
sion cycle must occur in a proper order if via- 
ble daughter cells are to be produced. The 
determination of functional sequence maps 
should illuminate the coordinating mecha- 
nisms that ensure that  a DroDer order of cell 
pathway Le., the product of A would be the 
substrate for B), although other explanations 
are also possible. A less obvious, but equally 
pertinent, example is the conclusion of Hart- 
well ('76) that two of the yeast "nuclear divi- 
sion" mutants must actually be defective in 
the fine details of DNA synthesis. 
Three main approaches to the determina- 
tion of functional sequence maps are available 
at the present time. Each approach has its 
limitations and its potential complications, as 
I have tried to indicate in the discussion that 
follows. This discussion is necessarily brief 
and somewhat abstract, and my list of poten- 
tial complications is certainly not exhaus- 
tive.6 Thus, the reader interested in applying 
these approaches is urged both to spend some 
time imagining possible complications and to 
study carefully the several papers in which 
these approaches have been applied to real ex- 
perimental systems (Coote and Mandelstam, 
'73; Jarvik and Botstein, '73; Hartwell et al., 
'74; Hereford and Hartwell, '74; Hartwell, '76; 
Nurse et  al., '76; Frankel e t  al., '76). 
For the discussion that follows, i t  is neces- 
sary to distinguish between the morphologi- 
cally and/or biochemically defined landmark 
events (denoted La, Lb, Lc, . . . and the pri-  
rnav defect events (denoted D1, D2, .  . . I  de- 
fined as the sites of the primary molecular 
defects due to particular cell cycle mutations 
or cell cycle-specific inhibitors.? Thus, we will 
consider how to obtain information both on 
the functional interrelatedness of landmark 
events and on the functional interrelatedness 
of primary defect events. However, i t  should 
be clear that this distinction is of practical, 
rather than fundamental, significance; i t  sim- 
ply reflects the fact that  from the properties 
of mutants we can infer the existence of cell 
cycle events for which we have no direct mor- 
phological or biochemical assays a t  the pres- 
ent time. Thus, although a mutant must be 
analyzed in terms of the landmark events that 
do or do not occur, the primary defect event for 
the mutant may or may not be the same as its 
*For example, I have not attempted to discuss in detail the com- 
plications that can arise when a gene product has two distinct func- 
cycle events is achieved (Hartwell, '74; Hart- tions (so that different mutant alleles of the gene might affect one 
function, or the other, or both). Note, however, that in this case (as 
maps should provide clues that  will be useful are reduced when multiple different mutant alleles of each gene 
have been analyzed. in elucidating the nature Of cY- ' Although written in terms of cell cycle mutants, most of the dis- 
cle events. For example, the determination of cussion that follows applies equally to the use of cell cycle-specific 
a dependent series A B, suggests that inhibitors, with the caveats that the danger of pleiotropic effects 
(see ftn. 5 )  is greater and that the benefits of being able to compare 
events A and B may be steps in a biochemical multiple different mutant alleles of the same gene are lacking. 
well e t  al., '74). Second, fUnCtiOna1 Sequence in others - see below) the chances of drawing erroneous conclusions 
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diagnostic landmark. (Figure 3 and the IN- 
TRODUCTION should help to make this clear.) 
In terms of functional sequence mapping, the 
diagnostic landmark must either be interde- 
pendent with the primary defect event ke., 
D1, La,) or subsequent to i t  in a dependent 
series (i.e., -QJ+ . ..A).' The same state- 
ment can be made about any other landmark 
that  fails to occur in the mutant, but i t  is cru- 
cial to realize that the various landmarks 
dependent on D 1  need not lie in the same 
dependent series (e.g., in fig. 2d let B = D1, C 
= La, and E = Lb). 
I t  is also important to note that the primary 
defect event for a particular mutant can be 
either in the synthesis or in the function of 
the mutant gene product, and that the syn- 
thesis of a gene product is a prerequisite for 
its function. Thus, if mutants 1 and 2 were 
conditional-for-synthesis and conditional- 
labile alleles, respectively, of the same gene, 
then a functional sequence map should show 
J& . . . (or, in some cases, D1. D2.). 
Various landmark events might be dependent 
on D2 (and hence, by the transitive rule, on D1 
as well), or on D1 alone (e.g., in fig. 2d let B = 
D1, E = D2, C = La, and H = Lb). 
Comparing the phenotypes of single mu- 
tants. In this "single mutant method", one 
shifts strains carrying single cell cycle muta- 
tions to restrictive conditions and monitors 
the landmark events that do and do not occur 
(Hartwell e t  al., "74; Nurse et  al., '76; Frankel 
e t  al., '76). This method is the only one of 
those to be discussed that yields information 
about the functional interrelatedness of land- 
mark events; sometimes i t  also yields infor- 
mation about the functional interrelatedness 
of primary defect events. Consider what can 
be learned from one such mutant, with a pri- 
mary defect event D1. If two landmark events 
(La and Lb) both fail to occur under restric- 
tive conditions, then each of them is depen- 
dent upon (or interdependent with) D1, but La 
and Lb may be interrelated in any of four pos- 
sible ways (Lb dependent on La, u; La dependent on Lb, D l .  Lb, &; 
interdependence, D1 La. Lb,; indepen- 
dence, A). If La and Lb are clearly Lb 
distinct in their temporal map positions, i t  
should be possible to rule out interdependence 
and one of the two possible dependent rela- 
tionships, but no discrimination between inde- 
pendence and the other dependent relation- 
ship is possible. If a third landmark event (Lc) 
occurs under the restrictive conditions, i t  may 
be related to D1 and La (or Lb) in two possible 
ways : Lc - 
Lc D1 La or - - - D1 La 
_ f -  
In some cases, temporal map data may allow 
the former of these relationships to be ruled 
out. [For example, the cdc24 mutants of yeast 
fail to form buds at restrictive temperatures, 
but do undergo nuclear division (Hartwell e t  
al., '73, '74). Since nuclear division occurs 
much later in the cycle than budding, this 
leads immediately to the conclusion that bud- 
ding and nuclear division are independent 
events.] 
A more detailed analysis is possible only if 
two or more mutants with different spectra of 
blocked and permitted landmarks are availa- 
ble for compari~on.~ If in  mutant 1 (primary 
defect event D1) landmark event La occurs 
but landmark event Lb does not, and in 
mutant 2 (primary defect event D2) Lb occurs 
but La does not, then a strong conclusion is 
possible: La and Lb are independent, as are D1 
and D2. [That is, in the functional sequence 
map, -U .. a .I The only apparent com- 
plication is the possibility that in one mutant 
a normal control mechanism has broken down. 
For example, in budding yeast, several muta- 
tions block cytokinesis but allow nuclear divi- 
sion, while every mutation or inhibitor tested 
to date that blocks nuclear division also blocks 
cytokinesis (Hartwell e t  al., '74). This has sug- 
gested (see below) that cytokinesis is depen- 
dent on the prior completion of nuclear divi- 
Throughout the following discussion, i t  is assumed that the 
category of landmark events and the category of primary defect 
events are mutually exclusive. Thus, each landmark event can be 
monitored biochemically or morphologically, but can only be blocked 
indirectly, by blocking a primary defect event upon which i t  is 
dependent; in contrast, each primary defect event can be directly 
and specifically blocked, but can only be monitored indirectly, by oh- 
serving its effects on landmark events. This assumption is conven- 
ient for discussion, and is appropriate for functional sequence m a p  
ping efforts at  the present time, Bince the molecular nature of the 
primary defect event is known for very few cell cycle mutants. How- 
ever, i t  should be clear that the availability of events that are si- 
multaneously landmark events and primary defect events will 
greatly facilitate the determination of functional sequence maps. In 
particular, analysis of the functional interrelatedness of landmark 
events by the "single mutant method" (next section) will be simpler, 
and will provide direct evidence for the existence of dependent 
series of landmark events. 
If the two mutants have the same spectra of blocked and permit- 
ted landmarks, but have terminal phenotypes that differ in some 
other way, a limited conclusion is possible, namely that their pri- 
mary defect events are not interdependent. Note, however, that an 
apparent identity of terminal phenotypes does not necessarily imply 
that the primary defect events are interdependent, since the a p  
parent identity might mean only that our assay procedures are in. 
sufficient to detect the differences in molecular events completed 
under restrictive conditions. 
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sion. The discovery a t  this point of a new 
mutant in which cytokinesis occurred despite 
the nonoccurrence of nuclear division would 
be less likely to suggest that cytokinesis and 
nuclear division are independent (the conclu- 
sion to which the above analysis would lead 
us) than that in the new mutant the normal 
control mechanism linking cytokinesis to nu- 
clear division is broken down (Nurse et al., 
’76). As should be apparent from this example, 
the best defense against this complication is 
to analyze as many different mutants with ef- 
fects on La or Lb as possible. The occasional 
mutants in which normal controls are broken 
down should be revealed as exceptions to the 
general patterns of apparent dependence rela- 
tionships. 
Another common situation is that in mu- 
tant 1 neither La nor Lb occurs, while in mu- 
tant 2 La occurs but Lb is blocked. Such data 
have generally been interpreted to mean that 
Lb is dependent on La (Hartwell et al., ’74; 
Nurse et al., ’76); the presumed dependence of 
cytokinesis upon nuclear division (see preced- 
ing paragraph) is a case in point. However, 
such an inference is not fully justified. 
Indeed, any of the following functional se- 
quence maps is compatible with these data: 
D1 La D2 Lb ; - - - _ _ .  (11 
La 
D1 /D2 Lb ; --_. (2) 
D2 
D1 La\, Lb ; 
_.- - (3) 
(41 
D2 Lb 
D l f L a  . -- --
If Lb clearly precedes La on the temporal map, 
possibilities (1) and (3) can be eliminated. 
Otherwise, further information on the func- 
tional interrelatedness of La and Lb can only 
come from characterizing additional mutants. 
The discovery of a mutant in which Lb occurs 
but La is blocked would suggest that possi- 
bilities (1) and (3) could be eliminated, al- 
though the possibility that a normal control 
had broken down (see preceding paragraph) 
would need to be considered. If no such mu- 
tant were found, while many different mu- 
tants in which neither La nor Lb occurred 
were found, the tentative inference that ei- 
ther map (1) or map (3) was correct would be 
justified. [This is in fact the situation for sev- 
eral of the dependence relationships deduced 
by Hartwell et  al. (’74) and Nurse et  al. (‘761, 
including the dependence of cytokinesis on 
nuclear division as mentioned above.] Note 
that neither temporal data nor the charac- 
terization of additional mutants can discrim- 
inate between maps (1) and (3) or between 
maps (2) and (4). Thus, to determine whether 
D 1  and D2 are independent or occur in a 
dependent series one must use other methods, 
of which the two most useful are described 
below. 
The method of comparing the phenotypes 
of single mutants has several pronounced 
merits. I t  provides information about the 
functional interrelatedness of landmark 
events, and its resolving power will increase 
as the number of events in the landmark 
category Ke., events for which biochemical or 
morphological assays are available) increases. 
The method utilizes strains carrying single 
mutations, and thus it is relatively easy to ap- 
ply in systems in which genetic manipulation 
is difficult. [Note, however, that some capaci- 
ty for genetic analysis is desirable, since it is 
important to provide direct evidence that the 
effects studied in a particular strain really 
are due to a single mutation.] There is no 
requirement that the mutants used remain 
viable during incubation under restrictive 
conditions, and leaky mutants should lead to 
the same conclusions as tight ones. Condi- 
tional-for-synthesis alleles should lead to the 
same conclusions about landmark events as 
do conditional-labile alleles, unless some land- 
marks are dependent on the synthesis, but not 
on the function, of the gene product. Even in 
this case, the conclusions drawn from study of 
a conditional-for-synthesis allele should be 
compatible with those drawn from study of a 
conditional-labile allele. Moreover, the meth- 
od seems immune to complications due to 
labile products of gene product function (cf. 
the discussion of the “reciprocal shift meth- 
od,” below). 
However, it should be clear that this meth- 
od also has its limitations and potential com- 
plications. I t  is crucial to remember the 
limitations imposed by the fact that the diag- 
nostic landmark for a given mutant cannot be 
assumed to be its primary defect event; in 
particular, note that the conclusion that one 
landmark event is dependent on another must 
always be tentative because of the chance 
that the mutant that would demonstrate 
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independence has not yet been isolated [recall 
maps (1)-(4), ab0ve1.l~ On the other hand, the 
conclusion that two events are independent 
should be tentative because of the possibility 
that a mutant has been isolated in which a 
normal control mechanism has broken down. 
Additional complications could arise if some 
sets of cell cycle events are triggered indepen- 
dently by a “clock’ (fig. 2b); in this case, a 
mutant that  caused the “clock“ to stop a t  a 
particular point could clearly give a mislead- 
ing impression tha t  later landmark events 
were dependent upon earlier ones. With re- 
gard to each of these potential complications, 
i t  is clear that the  probability of drawing 
valid and interesting conclusions about the 
functional interrelatedness of landmark 
events increases directly as the number of 
mutants analyzed. 
Finally, i t  should be clear that this method 
can provide only limited information about 
the functional interrelatedness of primary 
defect events. In some cases it can be con- 
cluded that the primary defect events are 
independent, in other cases (see ftn. 7) that 
they are not interdependent, and in other 
cases no conclusion can be drawn. It  is crucial 
to realize that the conclusions that can be 
drawn refer to the  primary defect events per 
se. In many cases, the primary defect event 
can be simply equated to gene product func- 
tion, in other cases it can be equated to gene 
product synthesis, but in still other cases the 
relationship may be more complicated. [For 
example, note that conditional-for-synthesis 
alleles that  were deficient, respectively, in 
polypeptide chain formation, an early stage of 
polypeptide chain folding, or a late stage of 
polypeptide chain folding, should show dif- 
ferent dependence relationships with events 
that were dependent, respectively, on mere 
presence of polypeptide chain, on presence of 
partly folded polypeptide chain, or on pres- 
ence of fully folded polypeptide chain.] The 
probability of correctly translating a func- 
tional sequence map of primary defect events 
into a functional sequence map of gene prod- 
uct synthesis events and gene product func- 
tion events clearly increases with the number 
of mutants (including the number of different 
alleles of each gene) analyzed. 
Comparing the terminal phenotypes of two 
single mutants to that of the corresponding dou- 
ble mutant. This “double mutant method” pro- 





interrelatedness of primary defect events in 
cases in which two mutants have the same 
spectra of blocked and permitted landmarks 
events, but have terminal phenotypes that 
differ in some other way (Coote and Man- 
delstam, ”73; Hereford and Hartwell, ’74).11 To 
apply the method, it is necessary to have two 
single mutant strains carrying different cell 
cycle mutations, as well as the double mutant 
strain carrying both mutations. I t  must be 
possible to impose restrictive conditions for 
both mutations simultaneously; thus, two 
temperature-sensitive mutations make a 
satisfactory pair, while a temperature-sensi- 
tive mutation and a cold-sensitive mutation 
do not. Each of the three strains is simply 
shifted to restrictive conditions, and their ter- 
minal phenotypes are compared. 
Interpretation of the results depends on the 
assumption that the terminal phenotypes of 
the single mutants differ because these 
strains complete different sets of normal cell 
cycle events under restrictive conditions, 
rather than because one of the mutant alleles 
results in a gene product that has acquired an 
abnormal activity. [This assumption is dif- 
ficult to test with any particular mutation. 
However, if several different mutant alleles of 
the same gene all behave similarly, the 
assumption is probably valid (Hereford and 
Hartwell, ’741.1 Granted this assumption, the 
logic of interpretation is as follows. First, the 
fact that the two single mutants have dif- 
ferent terminal phenotypes immediately 
eliminates the possibility that their primary 
defect events are interdependent (see also ftn. 
8). Second, if the two primary defect events oc- 
cur in a dependent sequence D1: D2,, then 
the terminal phenotype of the double mutant 
should be identical to that of mutant 1, since 
mutant 2 completes D1 (but not D2) under re- 
strictive conditions, while both mutant 1 and 
the double mutant complete neither D1 nor 
D2. Third, if the two primary defect events are 
independent, then the terminal phenotype of 
the double mutant (which completes neither 
lo Recall footnote I. 
1 %  The method is also sometimes useful in cases in which the land- 
mark events blocked in one mutant are a subset of those blocked in 
the other. For example, in the case described by maps 11)-(41 (pre- 
ceding section), a difference hetween the terminal phenotype of the 
double mutant and that of mutant 1 would he evidence that either 
map (3) or map (41 was correct Le., that D1 and D2 were indepen- 
dent), by the same reasoning (and subject to the same qualifica- 
tions) as described in the text. Note, in particular, that a failure to 
find such a difference would not he good evidence in favor of map (11 
or (2). 
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D1 nor D2 under restrictive conditions) should 
be different both from that of mutant 1 (which 
completes D2 but not D1) and from that of 
mutant 2 (which completes D1 but not D2). 
However, i t  is possible that the resolving 
power of presently available techniques may 
not be sufficient to distinguish the unique ter- 
minal phenotype of the double mutant from 
that of one or the other of the single mutants. 
Thus, the observation that the double mutant 
has a unique terminal phenotype constitutes 
strong evidence that  the primary defect 
events are independent. In contrast, the obser- 
vation that the terminal phenotype of the 
double mutant is indistinguishable from that 
of mutant 1 rules out the dependent sequence 
D2: Dl . ,  but cannot distinguish between 
the dependent series D1, D2. and the possi- 
bility that D1 and D2 are independent. 
The preceding comments on the expected 
behavior of the double mutant strains were 
based on the tacit assumption that at the time 
of the shift to restrictive conditions most cells 
in the population were either prior to  both 
relevant execution points or (what amounts to 
the same thing) after both relevant execution 
points. If this assumption is invalid, mislead- 
ing results can be obtained. In particular, if 
the primary defect events were related in a 
dependent series D1, D2,, and the execution 
point for mutation 1 preceded that for muta- 
tion 2 by a wide margin, then an asynchronous 
population of the double mutant would con- 
tain many cells (conceivably even the bulk of 
the population) that are between the two 
execution points. These cells will complete D1 
but not D2 under restrictive conditions, and 
their terminal phenotype will be the same as 
that of the single mutant 2, seemingly imply- 
ing that the sequence D l .  D2, can be ruled 
out. This danger can be avoided by experimen- 
tally measuring the execution points of the 
two single mutants. If these are too far apart, 
i t  may be possible to use other alleles of the 
same genes that have more favorable execu- 
tion points. Alternatively, i t  should be possi- 
ble to use synchronous cultures of the double 
mutant to ensure that most of the individual 
cells really do fail to complete both primary 
defect events under the restrictive conditions. 
I t  is important to note that, so long as the 
execution points are not too far apart, the 
method gives the same answer regardless of 
the actual order of the execution points. Thus, 
if conditional-labile alleles are used, the re- 
sults should suggest the correct order of gene 
product function, even if one (or both) of the 
mutant alleles used is somewhat leaky. Of 
course, if the mutant alleles used are condi- 
tional-for-synthesis, the conclusions drawn 
may be appropriate for the actual primary 
defect events rather than for gene product 
function events. 
In summary, when i t  can be applied, the 
double mutant method is a valuable approach 
to determining the functional interrelated- 
ness of primary defect events. It can be ap- 
plied using pairs of mutants of the same type 
(e.g., pairs of the relatively plentiful tempera- 
ture-sensitive mutants), although other com- 
binations are also possible (e.g., one mutant 
plus an inhibitor). There is no requirement 
that the mutants retain viability during in- 
cubation under restrictive conditions, and, 
provided reasonable precautions are taken to 
ensure that execution points are not too far 
apart, leaky mutants lead to the same conclu- 
sions as do tight ones. The method does require 
a significant genetic capability, since i t  is nec- 
essary to obtain (and to prove that you have 
obtained) both of the single mutant strains 
and the double mutant strain. This require- 
ment may be a serious obstacle to attempts to 
apply this method to some experimental sys- 
tems, such as animal cells. Moreover, the 
method is inherently limited in that i t  can 
provide strong evidence for the independence 
of two primary defect events, but not for the 
existence of a dependent sequence. 
Reciprocal shift experiments. The most gen- 
erally useful approach t o  the determination of 
functional sequence maps of primary defect 
events is the “reciprocal shift method” (Jar- 
vik and Botstein, ’73; Hereford and Hartwell, 
’74; Hartwell, ’76). The method can be used 
when two different cell cycle-specific blocks 
can be independently imposed on the same 
strain. [For example, a temperature-sensitive 
cell cycle mutant can be used in conjunction 
with a cell cycle-specific inhibitor (Hereford 
and Hartwell, ’74; Hartwell, ’76), or a strain 
carrying both a temperature-sensitive cell cy- 
cle mutation and a cold-sensitive cell cycle 
mutation can be used (Jarvik and Botstein, 
’73). In the latter case, it is essential that 
some intermediate temperature be permissive 
with respect to both mutations.] It is also nec- 
essary that each block be reversible; that is, 
the cells must remain viable (as judged by 
their ability to resume cell cycle progress upon 
a return to permissive conditions) during a pe- 
riod of incubation under restrictive condi- 
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tions. (It is not strictly necessary that recov- 
ery after a return to permissive conditions be 
rapid, although this will generally give 
cleaner experimental results.) I t  is, of course, 
easy to ascertain experimentally whether this 
condition is met. 
Given a suitable pair of mutants (and/or in- 
hibitors), two separate experiments must be 
performed. In the first experiment, the cells 
are initially exposed to conditions that are re- 
strictive for mutation or inhibitor 1 ( S O  that  
primary defect event D1 cannot be com- 
pleted), but permissive for mutation or inhib- 
itor 2 (so that primary defect event D2 can be 
completed unless it is dependent on D1). The 
cells must be left under these conditions long 
enough that all cells in a normal population 
would have completed event D2. Then, in 
order to determine whether D2 has in fact 
been completed by the cells in which D1 has 
been blocked, the cells are shifted to condi- 
tions permissive for D1 but restrictive for D2, 
and their ability to carry out cell division (or 
any other landmark event that  is dependent 
both on D1 and on D2) is monitored. If the 
cells are able to carry out the landmark event 
under conditions restrictive for D2, this event 
must have been completed during the first in- 
cubation, and the functional sequence map 
should show D2. D1, or a. If the cells are 
unable to carry out the landmark event during 
the second incubation, then D2 must not have 
been completed during the first incubation, 
and the functional sequence map should show -- D1 D2 or D1, D2,. In either case, it  is pos- 
sible to distinguish between the two remain- 
ing possibilities by performing a second ex- 
periment, in which the first incubation is re- 
strictive for D2 but not D1, and the second 
incubation is restrictive for D1  but not D2. 
I t  is worth noting that the logic of the re- 
ciprocal shift method is really quite similar to 
that of the single mutant method. However, 
rather than simply determining what land- 
mark events occurred during the first incuba- 
tion, one must use a second incubation to 
determine what primary defect events oc- 
curred during the first incubation. Since one 
is asking about relations between primary 
defect events, which can be directly and speci- 
fically blocked, it is possible to obtain direct 
evidence for the existence of dependent series 
(cf. discussion of the single mutant method, 
above). The reciprocal shift method provides 
no new information in cases in which the 
D2 
single mutant method demonstrates indepen- 
dence of landmarks and primary defect 
events. In cases in which the single mutant 
method provides little or no information (two 
mutations block exactly the same landmark 
events, or the landmark events blocked by one 
mutation are a subset of those blocked by the 
other), the reciprocal shift method can provide 
additional information about the functional 
interrelatedness of primary defect events but 
not of landmark events. For example, in the 
case described by maps (1)-(4) (see section on 
the single mutant method), the reciprocal 
shift method could rule out either maps (3) 
and (4) or maps (1) and (21, but could not dis- 
tinguish between map (1) and map (21, or be- 
tween map (3) and map (4). 
In interpreting the results of reciprocal 
shift experiments, several potentially serious 
complications must be kept in mind. First, i t  
should be clear that  the conclusions obtained 
relate to the primary defect events per se; as 
mentioned above (last paragraph of the sec- 
tion on the single mutant method), these can 
usually, but not always, be simply equated 
either to gene product synthesis events or to 
gene product function events. (It is a useful 
exercise to try to define the circumstances 
that would allow the functional sequence gene 
product synthesis- gene product function to be 
deduced from reciprocal shift experiAents 
involving a conditional-labile allele and a con- 
ditional-for-synthesis allele of the same gene.) 
Moreover, the situation is further complicated 
by the fact that  what the reciprocal shift ex- 
periments really provide is an “order of ex- 
ecutability”: they tell us whether the execu- 
tion point for block 2 can be passed while block 
1 is imposed on the cells, and vice versa. This 
order of executability may or may not be the 
same as the functional sequence of the pri- 
mary defect events. For example, suppose that 
the primary defect events for a pair of mu- 
tants actually occur in the dependent se- 
quence D1. D2,, but that  mutant 1 is tight, 
while mutant 2 is sufficiently leaky that its 
execution point is significantly earlier in the 
cell cycle than the time a t  which event D1 oc- 
curs. Under these conditions, reciprocal shift 
experiments would show that execution point 
2 could be passed while event D1 was blocked, 
and vice versa, suggesting (erroneously) that  
D1  and D2 were independent. In a second 
important example, suppose that D1 and D2 
are actually interdependent, but that  mutant 
1 is tight while mutant 2 is sufficiently leaky 
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that  its execution point can be passed while 
D1 is blocked. Now the results of reciprocal 
shift experiments would suggest (erroneously) 
the functional sequence D2, Dl+. Since the 
order of executability is of considerably less in- 
trinsic interest than the functional sequence 
map of primary defect events, i t  is clearly de- 
sirable to do reciprocal shift experiments with 
tight conditional-labile or conditional-for-syn- 
thesis alleles. The problem of identifying 
these tight alleles has been discussed above 
(see section on temporal mapping), but it is 
worth reiterating that the odds improve di- 
rectly as the number of mutants available for 
analysis. 
Another possible complication is that one 
gene product may produce a substance that is 
labile, or induce a state that is transitory (Jar- 
vik and Botstein, '73). In the course of a nor- 
mal cell cycle, this substance or state would be 
quickly operated upon by subsequent gene 
products. However, the protocol for reciprocal 
shift experiments demands that the cells be 
held in the first incubation long enough for all 
cells to complete the permitted event (if they 
can). Thus, i t  is possible that during the first 
incubation the cells will in fact have com- 
pleted the permitted event, but that the sub- 
stance or state produced by completing the 
permitted event will have been dissipated in 
most cells by the time that the shift to the sec- 
ond incubation is made. The result would be a 
failure to complete the later landmarks dur- 
ing the second incubation, and the erroneous 
conclusion that the permitted event had not 
been completed during the first incubation be- 
cause it was dependent on the restricted 
event. For example, if the actual functional 
sequence of primary defect events were - D2 , but D1 produced a labile product, the 
erroneous conclusion that D1 and D2 were in- 
terdependent could be drawn (Hereford and 
Hartwell, '74). Similarly, if D1 and D2 were 
independent, but D1 produced a labile prod- 
uct, the erroneous conclusion that D1 was 
dependent on D2 i D2. D1,) could be drawn. 
The possible complication under discussion is 
a particularly nasty one, since comparing the 
results obtained with different mutant alleles 
of the same genes is not likely to reveal the ex- 
istence of-the problem. The only apparent pro- 
tection against this complication is to mini- 
mize the opportunity for lability to be ex- 
pressed, by minimizing the length of the first 
incubation (presynchronized cultures would 
be useful in this regard), and by using (where 
possible) mutants that recover quickly upon a 
return to permissive conditions. 
Application of the reciprocal shift method 
will probably be limited primarily by the 
availability of suitable pairs of mutant and in- 
hibitor blocks that can be independently and 
reversibly imposed. The approach with the 
widest potential applicability seems to be the 
use of double mutants containing both a tem- 
perature-sensitive and a cold-sensitive muta- 
tion, as pioneered by Jarvik and Botstein ('73) 
in studies of bacteriophage. Jarvik and Bot- 
stein ('75) subsequently described what 
should be a powerful approach to collecting 
large numbers of temperature-sensitive and 
cold-sensitive mutants suitable for use in re- 
ciprocal shift experiments. However, applica- 
tion of these approaches demands a signifi- 
cant capability for genetic analysis. This 
should not prevent their application to bac- 
teria, yeast, and other microorganisms, but 
will probably be a serious obstacle to their use 
with animal cells. I t  may be feasible to start 
with a parent cell line that is temperature- 
sensitive but not cold-sensitive, select cold- 
sensitive cell cycle mutants in this genetic 
background, and then do reciprocal shift ex- 
periments on the putative double mutants. 
However, the problems of showing that one 
really has mutations in two different genes, 
and of relating the results obtained with one 
strain to those obtained with others, do not 
seem trivial. 
In contrast, an approach that should be 
readily applicable to animal cells as well as to 
other systems is the use of inhibitors in con- 
junction with temperature-sensitive or cold- 
sensitive mutations. The applicability of this 
method should be limited only by the number 
of good cell cycle-specific inhibitors that  can 
be obtained. The method has already given 
very important results in studies of yeast 
(Hereford and Hartwell, '74; Hartwell, '76). 
Utilizing miscellaneous clues and cross- 
checking the conclusions reached with different 
approaches. I t  should be clear from the preced- 
ing discussion that the available methods for 
attempting to derive functional sequence 
maps present a variety of opportunities to 
draw erroneous conclusions. This fact seems to 
me to have four general morals. First, it is 
clearly desirable to include in the analysis as 
many different mutants and inhibitors as pos- 
sible; as emphasized repeatedly above, this 
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will often allow potentially misleading data to 
be recognized as such. Second, since the dif- 
ferent approaches are subject to somewhat 
different artifacts, i t  is clearly desirable to 
cross-check the conclusions drawn using dif- 
ferent approaches. (Note in particular that 
the reciprocal shift and double mutant meth- 
ods are affected quite differently by leakiness 
of the mutants used.) Third, any ancillary evi- 
dence that can be adduced to support a pro- 
posed sequence is most welcome. [A good 
example is the use by Hereford and Hartwell 
('74) of data on the protein synthesis require- 
ments of the cdc4 and cdc? mutants to support 
the sequence suggested by the double mutant 
approach.1 Finally, it seems clear that all con- 
clusions about functional sequences, and par- 
ticularly conclusions in which primary defect 
events have been translated into gene product 
synthesis events and gene product function 
events, should be regarded as tentative until 
the actual molecular mechanisms of cell cycle 
progress are known. 
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